Medication Adherence and Symptom Reduction in Adults Treated with Mixed Amphetamine Salts in a Randomized Crossover Study

References

• . Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York, NY: Guilford Press; 2005
   Google Scholar
• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004; 7(1):77–97
   PubMed Web of Science ®Google Scholar
• . Adler LA, Zimmerman B, Starr HL, . efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol. 2009; 29(3):239–247
   PubMed Web of Science ®Google Scholar
• . Spencer TJ, Adler LA, McGough JJ, . efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007; 61(12):1380–1387
   PubMed Web of Science ®Google Scholar
• . Weisler RH, Biederman J, Spencer TJ, . Mixed amphetamine salts extended-release in the treatment of adult ADHD: A randomized, controlled trial. CNS Spectr. 2006; 11(8):625–639
   PubMed Web of Science ®Google Scholar
• . Adler LA, Goodman DW, Kollins SH, ; 303 Study Group. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatr. 2008; 69(9):1364–1373
   PubMed Web of Science ®Google Scholar
• . Hinkin CH, Castellon SA, Durvasula RS, . Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology. 2002; 59(12):1944–1950
   PubMed Web of Science ®Google Scholar
• . Winkler A, Teuscher AU, Mueller B, Diem P. Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly. 2002; 132(27–28):379–385
   PubMed Web of Science ®Google Scholar
• . Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes. Med Care. 2006; 44(4):300–303
   PubMed Web of Science ®Google Scholar
• . Diaz E, Levine HB, Sullivan MC, . Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci. 2001; 26(4):325–329
   PubMed Web of Science ®Google Scholar
• . Cascade E, Kalali AH, Weisler RH. Short-acting versus long-acting medications for the treatment of ADHD. Psychiatry. 2008; 5(8):24–27
   PubMedGoogle Scholar
• . Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010; 122(1):184–191
   PubMed Web of Science ®Google Scholar
• . Sanchez RJ, Crismon ML, Barner JC, Bettinger T, Wilson JP. Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy. 2005; 25(7):909–917
   PubMed Web of Science ®Google Scholar
• . Safren SA, Duran P, Yovel I, Perlman CA, Sprich S. Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord. 2007; 10(3):257–260
   PubMedGoogle Scholar
• . Deschamps AE, Graeve VD, van Wijngaerden E, . Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDs. 2004; 18(11):644–657
   PubMed Web of Science ®Google Scholar
• . de Bruin M, Hospers HJ, van den Borne HW, Kok G, Prins JM. Theory-and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: A pilot study. AIDS Patient Care STDs. 2005; 19(6):384–394
   PubMed Web of Science ®Google Scholar
• . Boyle BA, Jayaweera D, Witt MD, Grimm K, Maa JF, Seekins DW. Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression. HIV Clin Trials. 2008; 9(3):164–176
   PubMed Web of Science ®Google Scholar
• . Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther. 2004; 42(4):409–422
   PubMed Web of Science ®Google Scholar
• . Rosen MI, Beauvais JE, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Neuropsychological correlates of suboptimal adherence to metformin. J Behav Med. 2003; 26(4):349–360
   PubMed Web of Science ®Google Scholar
• . Lee MS, Lee HY, Kang SG, . Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. J Affect Disord. 2010; 123(1–3):216–221
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
   Google Scholar
• . Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004; 27(2): 187–201
   PubMed Web of Science ®Google Scholar
• . First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV-TR Axis I Disorders—Patient Edition (SCID-I/P). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 2002
   Google Scholar
• . DuPaul GJ, George J, Power TJ, Anastopoulos AD. ADHD Rating Scale—IV: Checklists, Norms, and Clinical Interpretation. New York, NY: The Guilford Press; 1998
   Google Scholar
• . Spencer TJ, Adler LA, Weisler RH, Youcha SH. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: A randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatr. 2008; 69(9):1437–1448
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Haight BR, Horrigan JP, . Bupropion XL in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study. Biol Psychiatry. 2005; 57(7):793–801
   PubMed Web of Science ®Google Scholar
• . Adler LA, Spencer TJ, Biederman J, . The internal consistency and validity of the Attention-deficit/hyperactivity Disorder Rating Scale (ADHD-RS) with adult ADHD prompts as assessed during a clinical treatment trial. J ADHD Relat Disord. 2009; 1(1):14–24
   Google Scholar
• . Guy W. Clinical global impressions. In: Guy W, ed. ECDEU Assessment Manual for Psychopharmacology (Revised). Rockville, MD: National Institute of Mental Health; 1976:217–221
   Google Scholar
• . Adler LA, Spencer T, Faraone SV, . Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry. 2006; 18(3):145–148
   PubMedGoogle Scholar
• . Spencer TJ, Abikoff HB, Connor DF, . efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther. 2006; 28(3): 402–418
   PubMed Web of Science ®Google Scholar
• . Liu HH, Golin CE, Miller LG, . A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001; 134(10):968–977
   PubMed Web of Science ®Google Scholar
• . Spencer T, Biederman J, Wilens T, . Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001; 58(8):775–782
   PubMed Web of Science ®Google Scholar
• . Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993; 153(16):1863–1868
   PubMed Web of Science ®Google Scholar